awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38074429-D474B228-E164-4F1B-A50D-6260A79055BC
Q38074429-D474B228-E164-4F1B-A50D-6260A79055BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38074429-D474B228-E164-4F1B-A50D-6260A79055BC
New agents on the horizon in hepatocellular carcinoma.
P2860
Q38074429-D474B228-E164-4F1B-A50D-6260A79055BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38074429-D474B228-E164-4F1B-A50D-6260A79055BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c61248141a5bf6d3f9e643be18b9e400be5e423
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.